SEGMENTS (Tables)

6 Months Ended

Jun. 30, 2021

SEGMENTS [Abstract]

Summarized Financial Information Concerning Reportable Segments

Summarized financial information concerning reportable segments is shown in the following tables:

Three Months Ended June 30, 2021
	ADMA BioManufacturing			Plasma Collection Centers			Corporate			Consolidated
Revenues	$	16,347,880		$	1,447,001		$	35,709		$	17,830,590
Cost of product revenue		17,382,292			1,450,332			-			18,832,624
Loss from operations		(8,337,405	)		(2,794,219	)		(4,449,608	)		(15,581,232	)
Interest and other expense, net		(78,793	)		(366	)		(3,244,912	)		(3,324,071	)
Net loss		(8,416,198	)		(2,794,585	)		(7,694,520	)		(18,905,303	)
Depreciation and amortization expense		1,055,537			268,927			1,530			1,325,994
Total assets		169,799,509			20,593,411			42,420,872			232,813,792

Three Months Ended June 30, 2020
	ADMA BioManufacturing			Plasma Collection Centers			Corporate			Consolidated
Revenues	$	6,502,865		$	1,249,020		$	35,709		$	7,787,594
Cost of product revenue		12,237,141			1,258,488			-			13,495,629
Loss from operations		(12,852,835	)		(919,309	)		(3,351,681	)		(17,123,825	)
Interest and other expense, net		(235,442	)		(33	)		(2,818,791	)		(3,054,266	)
Net loss		(13,088,277	)		(919,342	)		(6,170,472	)		(20,178,091	)
Depreciation and amortization expense		772,241			111,106			2,305			885,652
Total assets		109,105,418			7,542,486			74,893,664			191,541,568

Six Months Ended June 30, 2021
	ADMA BioManufacturing			Plasma Collection Centers			Corporate			Consolidated
Revenues	$	29,768,923		$	4,038,868		$	71,417		$	33,879,208
Cost of product revenue		32,832,049			3,770,697			-			36,602,746
Loss from operations		(17,843,093	)		(4,765,060	)		(8,137,328	)		(30,745,481	)
Interest and other expense, net		(100,307	)		(750	)		(6,438,706	)		(6,539,763	)
Net loss		(17,943,400	)		(4,765,810	)		(14,576,034	)		(37,285,244	)
Capital expenditures		2,725,432			4,321,303			-			7,046,735
Depreciation and amortization expense		2,065,307			486,918			3,397			2,555,622

Six Months Ended June 30, 2020
	ADMA BioManufacturing			Plasma Collection Centers			Corporate			Consolidated
Revenues	$	14,246,139		$	3,669,782		$	71,417		$	17,987,338
Cost of product revenue		26,689,094			3,635,761			-			30,324,855
Loss from operations		(25,328,980	)		(1,376,464	)		(7,188,167	)		(33,893,611	)
Interest and other expense, net		(474,314	)		(33	)		(5,055,363	)		(5,529,710	)
Net loss		(25,803,294	)		(1,376,497	)		(12,243,530	)		(39,423,321	)
Capital expenditures		5,064,494			1,178,790			-			6,243,284
Depreciation and amortization expense		1,447,214			222,395			4,881			1,674,490

Net Revenues According to Geographic Area

Net revenues according to geographic area, based on the location of where the product is shipped, is as follows:

	Three Months Ended June 30,				Six Months Ended June 30,
	2021		2020		2021		2020
United States	$	15,424,839	$	6,797,170	$	29,102,848	$	15,453,443
International		2,405,751		990,424		4,776,360		2,533,895
Total revenues	$	17,830,590	$	7,787,594	$	33,879,208	$	17,987,338